HEADER TRANSFERASE/INHIBITOR 01-APR-20 6WE2 TITLE HUMAN PARP14 (ARTD8), CATALYTIC FRAGMENT IN COMPLEX WITH RBN012759 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 1 OF PROTEIN MONO-ADP-RIBOSYLTRANSFERASE PARP14; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 8,ARTD8,B COMPND 5 AGGRESSIVE LYMPHOMA PROTEIN 2,POLY [ADP-RIBOSE] POLYMERASE 14,PARP- COMPND 6 14; COMPND 7 EC: 2.4.2.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP14, BAL2, KIAA1268; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PARP14, ARTD8, MONOPARP, ADP RIBOSYLATION, INHIBITOR COMPLEX, KEYWDS 2 TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR K.K.SWINGER,L.B.SCHENKEL,K.W.KUNTZ REVDAT 3 18-OCT-23 6WE2 1 REMARK REVDAT 2 01-SEP-21 6WE2 1 JRNL REVDAT 1 24-MAR-21 6WE2 0 JRNL AUTH L.B.SCHENKEL,J.R.MOLINA,K.K.SWINGER,R.ABO,D.J.BLACKWELL, JRNL AUTH 2 A.Z.LU,A.E.CHEUNG,W.D.CHURCH,K.KUNII,K.G.KUPLAST-BARR, JRNL AUTH 3 C.R.MAJER,E.MINISSALE,J.R.MO,M.NIEPEL,C.REIK,Y.REN, JRNL AUTH 4 M.M.VASBINDER,T.J.WIGLE,V.M.RICHON,H.KEILHACK,K.W.KUNTZ JRNL TITL A POTENT AND SELECTIVE PARP14 INHIBITOR DECREASES PROTUMOR JRNL TITL 2 MACROPHAGE GENE EXPRESSION AND ELICITS INFLAMMATORY JRNL TITL 3 RESPONSES IN TUMOR EXPLANTS. JRNL REF CELL CHEM BIOL V. 28 1158 2021 JRNL REFN ESSN 2451-9456 JRNL PMID 33705687 JRNL DOI 10.1016/J.CHEMBIOL.2021.02.010 REMARK 2 REMARK 2 RESOLUTION. 2.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.5 REMARK 3 NUMBER OF REFLECTIONS : 13344 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.296 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 689 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.73 REMARK 3 REFLECTION IN BIN (WORKING SET) : 955 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.57 REMARK 3 BIN R VALUE (WORKING SET) : 0.3850 REMARK 3 BIN FREE R VALUE SET COUNT : 60 REMARK 3 BIN FREE R VALUE : 0.3590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2993 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 18 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.16 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.80000 REMARK 3 B22 (A**2) : 0.54000 REMARK 3 B33 (A**2) : -2.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.19000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.279 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.392 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.415 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.815 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.867 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3200 ; 0.003 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2728 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4357 ; 1.241 ; 1.683 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6364 ; 1.077 ; 1.603 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 375 ; 6.601 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 188 ;31.588 ;22.872 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 484 ;13.594 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;19.315 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 397 ; 0.041 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3637 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 705 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1497 ; 1.964 ; 4.654 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1496 ; 1.964 ; 4.653 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1873 ; 3.468 ; 6.962 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1874 ; 3.467 ; 6.963 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1702 ; 1.596 ; 4.796 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1703 ; 1.596 ; 4.796 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2479 ; 2.890 ; 7.141 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3409 ; 6.180 ;51.944 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3410 ; 6.179 ;51.947 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 1 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 1613 1801 B 1613 1801 5981 0.04 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6WE2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-NOV-20. REMARK 100 THE DEPOSITION ID IS D_1000248074. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13344 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.660 REMARK 200 RESOLUTION RANGE LOW (A) : 42.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.11700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.5 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.58200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: 3SMJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M AMMONIUM SULFATE; 0.1 M TRI REMARK 280 -SODIUM CITRATE PH 5.6; 25 % W/V PEG 4000, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.75000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.02500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.75000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 42.02500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA B 1706 REMARK 465 VAL B 1707 REMARK 465 LYS B 1761 REMARK 465 ASN B 1762 REMARK 465 PRO B 1763 REMARK 465 GLN B 1764 REMARK 465 ASN B 1765 REMARK 465 PRO B 1766 REMARK 465 THR B 1767 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1697 61.45 -114.99 REMARK 500 ASN A1698 -179.84 -69.89 REMARK 500 ALA A1706 156.76 -46.74 REMARK 500 LYS A1711 76.55 -100.38 REMARK 500 TYR A1727 -70.19 -99.89 REMARK 500 PHE B1697 62.50 -115.86 REMARK 500 LYS B1711 76.27 -102.29 REMARK 500 TYR B1727 -70.61 -99.35 REMARK 500 REMARK 500 REMARK: NULL DBREF 6WE2 A 1613 1801 UNP Q460N5 PAR14_HUMAN 1532 1720 DBREF 6WE2 B 1613 1801 UNP Q460N5 PAR14_HUMAN 1532 1720 SEQRES 1 A 189 LYS GLN GLN ASN PHE CYS VAL VAL GLU LEU LEU PRO SER SEQRES 2 A 189 ASP PRO GLU TYR ASN THR VAL ALA SER LYS PHE ASN GLN SEQRES 3 A 189 THR CYS SER HIS PHE ARG ILE GLU LYS ILE GLU ARG ILE SEQRES 4 A 189 GLN ASN PRO ASP LEU TRP ASN SER TYR GLN ALA LYS LYS SEQRES 5 A 189 LYS THR MET ASP ALA LYS ASN GLY GLN THR MET ASN GLU SEQRES 6 A 189 LYS GLN LEU PHE HIS GLY THR ASP ALA GLY SER VAL PRO SEQRES 7 A 189 HIS VAL ASN ARG ASN GLY PHE ASN ARG SER TYR ALA GLY SEQRES 8 A 189 LYS ASN ALA VAL ALA TYR GLY LYS GLY THR TYR PHE ALA SEQRES 9 A 189 VAL ASN ALA ASN TYR SER ALA ASN ASP THR TYR SER ARG SEQRES 10 A 189 PRO ASP ALA ASN GLY ARG LYS HIS VAL TYR TYR VAL ARG SEQRES 11 A 189 VAL LEU THR GLY ILE TYR THR HIS GLY ASN HIS SER LEU SEQRES 12 A 189 ILE VAL PRO PRO SER LYS ASN PRO GLN ASN PRO THR ASP SEQRES 13 A 189 LEU TYR ASP THR VAL THR ASP ASN VAL HIS HIS PRO SER SEQRES 14 A 189 LEU PHE VAL ALA PHE TYR ASP TYR GLN ALA TYR PRO GLU SEQRES 15 A 189 TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 189 LYS GLN GLN ASN PHE CYS VAL VAL GLU LEU LEU PRO SER SEQRES 2 B 189 ASP PRO GLU TYR ASN THR VAL ALA SER LYS PHE ASN GLN SEQRES 3 B 189 THR CYS SER HIS PHE ARG ILE GLU LYS ILE GLU ARG ILE SEQRES 4 B 189 GLN ASN PRO ASP LEU TRP ASN SER TYR GLN ALA LYS LYS SEQRES 5 B 189 LYS THR MET ASP ALA LYS ASN GLY GLN THR MET ASN GLU SEQRES 6 B 189 LYS GLN LEU PHE HIS GLY THR ASP ALA GLY SER VAL PRO SEQRES 7 B 189 HIS VAL ASN ARG ASN GLY PHE ASN ARG SER TYR ALA GLY SEQRES 8 B 189 LYS ASN ALA VAL ALA TYR GLY LYS GLY THR TYR PHE ALA SEQRES 9 B 189 VAL ASN ALA ASN TYR SER ALA ASN ASP THR TYR SER ARG SEQRES 10 B 189 PRO ASP ALA ASN GLY ARG LYS HIS VAL TYR TYR VAL ARG SEQRES 11 B 189 VAL LEU THR GLY ILE TYR THR HIS GLY ASN HIS SER LEU SEQRES 12 B 189 ILE VAL PRO PRO SER LYS ASN PRO GLN ASN PRO THR ASP SEQRES 13 B 189 LEU TYR ASP THR VAL THR ASP ASN VAL HIS HIS PRO SER SEQRES 14 B 189 LEU PHE VAL ALA PHE TYR ASP TYR GLN ALA TYR PRO GLU SEQRES 15 B 189 TYR LEU ILE THR PHE ARG LYS HET XBA A1901 26 HET EDO A1902 4 HET XBA B1901 26 HETNAM XBA 7-(CYCLOPROPYLMETHOXY)-5-FLUORO-2-{[(TRANS-4- HETNAM 2 XBA HYDROXYCYCLOHEXYL)SULFANYL]METHYL}QUINAZOLIN-4(3H)-ONE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 XBA 2(C19 H23 F N2 O3 S) FORMUL 4 EDO C2 H6 O2 FORMUL 6 HOH *18(H2 O) HELIX 1 AA1 ASP A 1626 ASN A 1637 1 12 HELIX 2 AA2 ASN A 1653 ALA A 1669 1 17 HELIX 3 AA3 ASP A 1685 GLY A 1687 5 3 HELIX 4 AA4 SER A 1688 GLY A 1696 1 9 HELIX 5 AA5 SER A 1700 ASN A 1705 5 6 HELIX 6 AA6 ASN A 1718 ALA A 1723 1 6 HELIX 7 AA7 ASP B 1626 ASN B 1637 1 12 HELIX 8 AA8 ASN B 1653 ALA B 1669 1 17 HELIX 9 AA9 ASP B 1685 GLY B 1687 5 3 HELIX 10 AB1 SER B 1688 GLY B 1696 1 9 HELIX 11 AB2 SER B 1700 ASN B 1705 5 6 HELIX 12 AB3 ASN B 1718 ALA B 1723 1 6 SHEET 1 AA1 5 CYS A1618 GLU A1621 0 SHEET 2 AA1 5 ARG A1644 GLN A1652 -1 O ARG A1650 N VAL A1620 SHEET 3 AA1 5 ALA A1791 ARG A1800 -1 O THR A1798 N GLU A1646 SHEET 4 AA1 5 LYS A1736 LEU A1744 -1 N LYS A1736 O PHE A1799 SHEET 5 AA1 5 GLU A1677 THR A1684 -1 N HIS A1682 O TYR A1739 SHEET 1 AA2 4 THR A1713 ALA A1716 0 SHEET 2 AA2 4 LEU A1782 ALA A1785 -1 O PHE A1783 N PHE A1715 SHEET 3 AA2 4 THR A1772 THR A1774 -1 N VAL A1773 O VAL A1784 SHEET 4 AA2 4 TYR A1748 HIS A1750 1 N THR A1749 O THR A1774 SHEET 1 AA3 2 SER A1760 ASN A1762 0 SHEET 2 AA3 2 ASN A1765 LEU A1769 -1 O ASP A1768 N LYS A1761 SHEET 1 AA4 5 CYS B1618 GLU B1621 0 SHEET 2 AA4 5 ARG B1644 GLN B1652 -1 O ARG B1650 N VAL B1620 SHEET 3 AA4 5 ALA B1791 ARG B1800 -1 O THR B1798 N GLU B1646 SHEET 4 AA4 5 LYS B1736 LEU B1744 -1 N LYS B1736 O PHE B1799 SHEET 5 AA4 5 GLU B1677 THR B1684 -1 N HIS B1682 O TYR B1739 SHEET 1 AA5 4 THR B1713 ALA B1716 0 SHEET 2 AA5 4 LEU B1782 ALA B1785 -1 O PHE B1783 N PHE B1715 SHEET 3 AA5 4 THR B1772 THR B1774 -1 N VAL B1773 O VAL B1784 SHEET 4 AA5 4 TYR B1748 HIS B1750 1 N THR B1749 O THR B1774 SSBOND 1 CYS A 1618 CYS A 1618 1555 2555 2.25 SSBOND 2 CYS B 1618 CYS B 1618 1555 2555 2.26 CRYST1 83.500 84.050 80.890 90.00 116.02 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011976 0.000000 0.005846 0.00000 SCALE2 0.000000 0.011898 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013757 0.00000